Reporte zur Charge 003C21N

Symptomtext

1st dose 30Apr2021; no 2nd dose; Sleeping the whole time; Congested; Trouble breathing; Low grade fever; 16 years old administered with the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleeping the whole time), NASAL CONGESTION (Congested), DYSPNOEA (Trouble breathing), PYREXIA (Low grade fever) and PRODUCT DOSE OMISSION ISSUE (1st dose 30Apr2021; no 2nd dose) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21N) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in February 2021. On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 years old administered with the vaccine). On 01-May-2021, the patient experienced SOMNOLENCE (Sleeping the whole time), NASAL CONGESTION (Congested), DYSPNOEA (Trouble breathing) and PYREXIA (Low grade fever). On 17-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (1st dose 30Apr2021; no 2nd dose). On 30-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 years old administered with the vaccine) had resolved. On 01-May-2021, SOMNOLENCE (Sleeping the whole time), NASAL CONGESTION (Congested), DYSPNOEA (Trouble breathing) and PYREXIA (Low grade fever) had resolved. On 17-Aug-2021, PRODUCT DOSE OMISSION ISSUE (1st dose 30Apr2021; no 2nd dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.